ESPR Stock Analysis: Buy, Sell, or Hold?
ESPR - Esperion Therapeutics, Inc.
$3.16
0.00 (0.00%)
▲
5d:
+0.32%
30d:
+0.96%
90d:
+20.61%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When ESPR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ESPR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ESPR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$10.23
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$6.35
50.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ESPR is currently trading at $3.16, which is considered extended relative to its 30-day fair value range of $3.13 to $3.15. From a valuation perspective, the stock is trading at a discount (Forward PE: 10.8) compared to its historical average (41.0). Remarkably, the market is currently pricing in an annual earnings decline of 35.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ESPR is in a strong uptrend. The price is currently testing key support at $3.14. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ESPR is in a strong uptrend. The price is currently testing key support at $3.14. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.13 -
$3.15
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
46.2%
Protect Your Profits
Holding ESPR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($3.19)
Trading Range Analysis
30-Day Trading Range
$3.13 -
$3.15
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.14
Resistance Level
$3.17
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.82
Wall Street Target
$3.19
(+0.9%)
Revenue Growth (YoY)
23.2%
Profit Margin
-1.8%
Valuation Discount vs History
-35.9% cheaper
PE vs Historical
10.8 vs 41.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-35.9%
(market-implied from PE analysis)
1-Year Target
$2.84
(-10%)
2-Year Target
$2.56
(-19%)
3-Year Target
$2.30
(-27%)
3-Yr Target (if PE normalizes)
(PE: 11→41)
$8.73
(+176%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.8 to 41.0
Stabilization Target:
$11.97
(+278.9%)
PE Expansion Potential:
+278.9%
Share & Embed Analysis
Last updated: June 23, 2026 5:25 PM ET
Data refreshes hourly during market hours. Next update: 6:25 PM
Data refreshes hourly during market hours. Next update: 6:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ESPR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Benjamin Halladay
SELL
6424 shares
2026-03-17
Benjamin Looker
SELL
5708 shares
2026-03-17
Benjamin Looker
SELL
1689 shares
2026-01-20
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 60 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 64 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 67 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 58 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 57 HOLD |
Advanced ESPR Option Strategies
Professional options setups generated by AI based on today's ESPR price and gamma walls.
